Q3 2017 Jaguar Health Inc Earnings Call

14/11/2017 16:30

Conference Call Jaguar Health Inc

Jaguar Health Inc Conference call will be held on Nov 14, 2017. During the earnings conference call's session Jaguar Health Inc will provide updated information and financial status.
Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.
In order to join the audio conferencing dial conference bridge and key in the PIN code, Contact Jaguar Health Inc for this information
Schedule an online conference with QCONF conference service and get 5 free calls with online conferencing.
We are an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals and horses. Canalevia is our lead prescription drug product candidate for the treatment of various forms of diarrhea in dogs. We achieved statistically significant results in a canine proof-of-concept study completed in February 2015, suggesting that Canalevia treatment is superior to placebo, with 91% of the Canalevia-treated dogs achieving a formed stool during the study versus 50% of the placebo-treated dogs. In December 2015 we initiated a pivotal trial to evaluate the safety and effectiveness of Canalevia for the treatment of acute diarrhea in dogs. Additionally, we are seeking a first to market introduction of Canalevia with a conditional approval for the indication of CID.    
Read more Conference Call

Jaguar Health Inc (JAGX)

201 Mission Street, San Francisco California 94105, United States